Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis
- 1 December 2007
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 195 (2) , e135-e141
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Increased Osteoprotegerin Serum Levels in Men with Coronary Artery DiseaseThe Journal of Clinical Endocrinology & Metabolism, 2003
- Osteoprotegerin, an endogenous antiosteoclast factor for protecting bone in rheumatoid arthritisArthritis & Rheumatism, 2002
- Osteoprotegerin Reduces Osteoclast Numbers and Prevents Bone Erosion in Collagen-Induced ArthritisThe American Journal of Pathology, 2002
- Serum Osteoprotegerin Levels Are Associated With the Presence and Severity of Coronary Artery DiseaseCirculation, 2002
- High levels of osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in serum of rheumatoid arthritis patients and their normalization after anti–tumor necrosis factor α treatmentArthritis & Rheumatism, 2002
- Differential Expression of Bone Matrix Regulatory Proteins in Human Atherosclerotic PlaquesArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Long-Term Prognostic Value of Coronary Calcification Detected by Electron-Beam Computed Tomography in Patients Undergoing Coronary AngiographyCirculation, 2001
- Osteoprotegerin: a link between osteoporosis and arterial calcification?The Lancet, 2001
- The role of osteoprotegerin and receptor activator of nuclear factor ?B ligand in the pathogenesis and treatment of rheumatoid arthritisArthritis & Rheumatism, 2001
- A Tale of Two DiseasesCirculation, 1999